Skip to content

EXOZ EXOZ Investing Cash Flow

Investing Cash Flow at other companies

Gevo logo
GevoGEVO
-$9.13M+95.5%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
$23.13M+112%
NAG
Niagen Bioscience, Inc. Common StockNAGE
$5.25M+16,491%
Nature's Sunshine Products logo
Nature's Sunshine ProductsNATR
-$2.48M-123%
Opko Health logo
Opko HealthOPK
-$1.8M-104%
Upexi logo
UpexiUPXI
-$6.49M

Other financials

Income statement

See full
Revenue$17.5K
Operating income-$2.4M-22.4%
Net income-$2.4M-27.7%
EPS (diluted)-$0.28-27.3%

Balance sheet

See full
Cash & equivalents$1.4M-83.0%
Total debt$1.2M-8.8%
Total equity$1.5M-82.8%
Total assets$4.0M-65.1%

Cash flow

See full
Operating cash flow-$1.5M-34.5%
CapEx$57.6K+85.5%
Free cash flow-$1.6M-35.8%

Valuation

See full
Market cap$76.8M-5.6%
Enterprise value$76.57M+1.0%
P/S1,096.1×

Profitability

See full
Operating margin-14,489.6%
Net margin-2,909.1%
FCF margin-10,117.8%

Returns & leverage

See full
Return on equity-185.8%
Debt / equity0.8×+0.6×
Current ratio1.3×-5.2×

Where this comes from

Reported directly by EXOZ in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: EXOZ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about EXOZ's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is EXOZ's investing cash flow?
EXOZ (EXOZ) reported investing cash flow of -$57.6K in Q1 2026.
How has EXOZ's investing cash flow changed year-over-year?
EXOZ's investing cash flow decreased by 85.5% year-over-year, from -$31.05K to -$57.6K.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.